Cover Image
市場調查報告書

HIV-1感染疾病:全球臨床實驗檢討

HIV-1 Infection Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 232265
出版日期 內容資訊 英文 164 Pages
訂單完成後即時交付
價格
Back to Top
HIV-1感染疾病:全球臨床實驗檢討 HIV-1 Infection Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月30日 內容資訊: 英文 164 Pages
簡介

HIV感染疾病是感染了人體免疫不全病毒所造成的疾病。這個感染疾病由於免疫系統遭到長期的破壞,讓身體缺乏與感染疾病抵抗的能力。HIV感染疾病有2種,第一型HIV感染性高,傳染力也強,散佈也快,擴展到全球的HIV感染疾病的大部分是這個類型造成的。相較下HIV-2形式散佈較慢,主要限定在西非洲。第一型HIV感染疾病,是透過血液、性的接觸,及母子間擴大傳染。一旦感染,最長10年間有可能沒有任何徵兆,但這段期間很可能擴大傳染。第一型HIV的症狀為發燒,頭痛,喉嚨疼痛,腹瀉,口腔潰爛、各種類型的皮疹、淋巴腺腫,疲勞,陰道內酵母菌感染,肌肉疼痛等。治療有組合抗病毒治療藥。愛滋病病毒第一型感染患者,為了避免病毒對藥產生耐藥性,必須服用所有藥物。併發症有HIV相關的癡呆症,癌症,HIV相關脂肪代謝障礙,慢性的體重減少,像念珠菌感染般的機會性感染症等。

本報告提供HIV-1感染疾病相關臨床研究之最新趨勢相關分析,為您彙整疾病·治療方法概要,及G7各國的臨床實驗狀況,各地區、Phase、階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • HIV-1感染疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: HIV-1感染疾病臨床實驗數量上感染疾病臨床實驗數量所佔的比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: HIV-1感染疾病臨床實驗數量上感染疾病臨床實驗數量所佔的比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - HIV-1感染疾病治療藥

有潛力的藥劑

最新臨床實驗新聞: HIV-1感染疾病

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • GlaxoSmithKline plc
    • Gilead Sciences, Inc.
    • Merck & Co., Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Johnson & Johnson
    • Bristol-Myers Squibb Company
    • Abbott Laboratories
    • Janssen R&D Ireland
  • 有代表性的研究機關/醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • French National Agency for Research on AIDS and Viral Hepatitis
    • AIDS Clinical Trials Group
    • University of California, San Francisco
    • Hospital Clinic de Barcelona
    • University of Washington
    • Imperial College London
    • University of North Carolina
    • International Partnership For Microbicides
    • Medical Research Council

5大臨床實驗簡介 1

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2454CTIDB

GlobalData's clinical trial report, "HIV-1 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • HIV-1 Infection
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of HIV-1 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of HIV-1 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of HIV-1 Infection
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in HIV-1 Infection Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on HIV-1 Infection
    • Nov 11, 2014: AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting 2014
    • Nov 03, 2014: Merck Announces Data from 48-Week Phase 2b Study of Investigational HIV Therapy Doravirine (MK-1439) in Treatment-Naive Patients
    • Oct 13, 2014: CytoDyn Announces 100% Success With PRO 140 in Four-Week Monotherapy Clinical Trial
    • Sep 24, 2014: Gilead's Investigational Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Meets 48-Week Primary Objective in Two Phase 3 Studies
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Janssen R&D Ireland
      • Clinical Trial Overview of Janssen R&D Ireland
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • French National Agency for Research on AIDS and Viral Hepatitis
      • Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
      • AIDS Clinical Trials Group
      • Clinical Trial Overview of AIDS Clinical Trials Group
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Hospital Clinic de Barcelona
      • Clinical Trial Overview of Hospital Clinic de Barcelona
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • University of North Carolina
      • Clinical Trial Overview of University of North Carolina
      • International Partnership For Microbicides
      • Clinical Trial Overview of International Partnership For Microbicides
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Region, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • HIV-1 Infection Therapeutics, Global, Suspended Clinical Trials, 2014*
  • HIV-1 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • HIV-1 Infection Therapeutics, Global, Terminated Clinical Trials, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • HIV-1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen R&D Ireland, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Clinical Trials Group, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of North Carolina, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by International Partnership For Microbicides, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014*

List of Figures

  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • HIV-1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top